Guerra Marcy L, Kalwat Michael A, McGlynn Kathleen, Cobb Melanie H
Department of Pharmacology UT Southwestern Medical Center Dallas TX USA; Present address: Stem Synergy Therapeutics Nashville TN USA.
Department of Pharmacology UT Southwestern Medical Center Dallas TX USA.
FEBS Open Bio. 2017 Jan 18;7(2):174-186. doi: 10.1002/2211-5463.12172. eCollection 2017 Feb.
The sweetener sucralose can signal through its GPCR receptor to induce insulin secretion from pancreatic β cells, but the downstream signaling pathways involved are not well-understood. Here we measure responses to sucralose, glucagon-like peptide 1, and amino acids in MIN6 β cells. Our data suggest a signaling axis, whereby sucralose induces calcium and cAMP, activation of ERK1/2, and site-specific phosphorylation of ribosomal protein S6. Interestingly, sucralose acted independently of mTORC1 or ribosomal S6 kinase (RSK). These results suggest that sweeteners like sucralose can influence β-cell responses to secretagogues like glucose through metabolic as well as GPCR-mediated pathways. Future investigation of novel sweet taste receptor signaling pathways in β cells will have implications for diabetes and other emergent fields involving these receptors.
甜味剂三氯蔗糖可通过其GPCR受体发出信号,诱导胰腺β细胞分泌胰岛素,但其中涉及的下游信号通路尚不清楚。在这里,我们检测了MIN6 β细胞对三氯蔗糖、胰高血糖素样肽1和氨基酸的反应。我们的数据表明存在一条信号轴,即三氯蔗糖可诱导钙和环磷酸腺苷(cAMP)的产生、细胞外信号调节激酶1/2(ERK1/2)的激活以及核糖体蛋白S6的位点特异性磷酸化。有趣的是,三氯蔗糖的作用独立于哺乳动物雷帕霉素靶蛋白复合体1(mTORC1)或核糖体S6激酶(RSK)。这些结果表明,像三氯蔗糖这样的甜味剂可通过代谢途径以及GPCR介导的途径影响β细胞对葡萄糖等促分泌剂的反应。未来对β细胞中新型甜味味觉受体信号通路的研究将对糖尿病及涉及这些受体的其他新兴领域产生影响。